Johnson & Johnson
JNJ · Healthcare · · USDFahodi Score BUY Short-term (Swing)
76
/ 100
Technical
100
Trend & RS
78
Momentum
68
Fundamental (0%)
83
Macro
24
Liquidity
73
| Component | Score | Weight |
|---|---|---|
| Technical | 100.0 | 40% |
| Trend & RS | 77.5 | 20% |
| Momentum | 67.8 | 20% |
| Fundamental | 83.3 | 0% |
| Macro | 23.8 | 15% |
| Liquidity | 72.8 | 5% |
Trade Setup
| Entry | 272.32 |
| Stop Loss | 258.02 (5.2%) |
| Target 1 (1:1) | 286.62 (+5.2%) |
| Target 2 (2:1) | 300.92 (+10.5%) |
| ATR(14) | 7.15 (2.6%) |
| Risk per Share | 14.30 |
| Reward:Risk | 2:1 |
ATR-based levels. Adjust for support/resistance zones.
Factor Profile
| Factor | Score | Z | Bar |
|---|---|---|---|
| Value | 25.5 | -0.98 | |
| Momentum | 67.8 | +0.71 | |
| Quality | 42.4 | -0.30 | |
| Composite | 45.2 | ||
Quality Scores
Piotroski F-Score
6
/9 —
Average
✓
✓
✗
✗
✓
✗
✓
✓
✓
1. Positive Net Income
2. Positive Roa
3. Positive Cfo
4. Quality Earnings
5. Lower Leverage
6. Higher Liquidity
7. No Dilution
8. Higher Gross Margin
9. Higher Asset Turnover
Altman Z-Score
9.94
—
Safe Zone
Distress <1.81Grey 1.81–2.99>2.99 Safe
Valuation vs Peers Overvalued
| Metric | Stock | Sector | vs Peers |
|---|---|---|---|
| P/E Ratio | 41.3 | 22.0 | +88% above |
| P/B Ratio | 8.0 | 4.0 | Above |
| Dividend Yield | 2.0% | 1.5% | Above avg |
Comparing against Healthcare median multiples.
Trading at a premium to sector peers — verify growth justifies premium.
Intrinsic Value (DCF) Significantly Overvalued
Intrinsic Value
96.16
vs
Market Price
272.32
Upside
-64.7%
| Margin of Safety | -183.2% |
| Stage 1 PV (5yr FCF) | 58,243,482,450 |
| Terminal Value PV | 173,246,826,910 |
| Total Enterprise Value | 231,490,309,360 |
Assumptions
| Base FCF | 12,691,339,722 |
| Growth Rate (5yr) | 5.9% |
| Terminal Growth | 2.5% |
| Discount Rate (WACC) | 9.0% |
2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.
Position Sizing — Kelly Criterion
4.6%
Recommended Size
49.43%
Full Kelly
24.71%
Half Kelly
5.0%
Max Cap (Moderate)
Kelly inputs derived from quant score 76/100. Estimated win rate 63%, avg win 9.6%, avg loss 3.5%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.
RECOVERY
Regime: RECOVERY (40% confidence) — position size reduced 8%
Signal Summary STRONG BUY
4
Bullish Signals
0
Bearish Signals
56.27
RSI(14)
2.8969
MACD
Relative Strength (RS) NEUTRAL
68
/ 99
RS Rating
O'Neil filter: <80
| RS vs SPY | → FLAT (+10.5% vs SPY 3M) |
| RS vs Sector | UNDERPERFORMING (Healthcare) |
| RS New High | ✓ RS at 3-month high Institutional accumulation signal |
| Sector Outperformance | -5.4% (3M) |
RS Line — stock / SPY (90 bars)
← older
newer →
RS vs SPY
50-day SMA of RS
NEUTRAL:
In line with the market — no strong outperformance or underperformance.
Technical Indicators
| Indicator | Value | Signal |
|---|---|---|
| Rsi | 56.27 | NEUTRAL |
| Macd | 2.8969 | BULLISH |
| Ma Cross | 265.58 / 246.46 | GOLDEN CROSS |
| Trend Short | ABOVE SMA50 | |
| Trend Long | ABOVE SMA200 | |
| Bollinger | MIDDLE | |
| Volume | 1.21x | NORMAL |
Key Levels
| Level | Price |
|---|---|
| 52-Week High | 282.02 |
| Bollinger Upper | 280.25 |
| SMA(200) | 246.46 |
| SMA(50) | 265.58 |
| SMA(20) | 263.94 |
| Current Price | 272.32 |
| Bollinger Lower | 247.62 |
| 52-Week Low | 185.12 |
| ATR(14) | 7.15 |
Advanced Technical Analysis
Click to expand
Wyckoff Phase & Volume Spread Analysis
Wyckoff Phase
ACCUMULATION E
Confidence
50%
Acc: 1.0 |
Dist: 1.0 |
Markup: 0.0 |
Markdown: 0.0
Volume Spread Analysis (last 5 bars)
| Date | Signal | Vol | Description |
|---|---|---|---|
| 2026-10-30 | Normal | 1.13x | Normal bar — no special VSA pattern |
| 2026-11-02 | Normal | 1.04x | Normal bar — no special VSA pattern |
| 2026-11-03 | Normal | 0.82x | Normal bar — no special VSA pattern |
| 2026-11-04 | Normal | 1.21x | Normal bar — no special VSA pattern |
| 2026-11-05 | Normal | 1.21x | Normal bar — no special VSA pattern |
Ichimoku Cloud BULLISH
| Line | Value | Status |
|---|---|---|
| Tenkan-sen (9) | 273.11 | Above Kijun |
| Kijun-sen (26) | 263.59 | Base line |
| Senkou A | 268.35 | Leading span A |
| Senkou B | 263.59 | Leading span B |
| Cloud | 263.59 – 268.35 | Bullish (Green) |
| Price vs Cloud | 272.32 | Above Cloud |
| Chikou Span | 258.66 | Bullish |
| Alignment Score | 4/4 | BULLISH |
TTM Squeeze & Divergences
TTM Squeeze
SQUEEZE OFF
No squeeze
Momentum:
BULLISH FADING
BB: 247.62 – 280.25 | KC: 252.54 – 275.33
Divergences (last 60 bars)
| Type | Indicator | Bars Ago | Strength |
|---|---|---|---|
| Regular Bullish | RSI | 18 |
Anchored VWAP
VWAP: 235.83
Anchor: 2025-11-10 (52w Low)
ABOVE AVWAP
+15.5%
Heikin-Ashi Trend
WEAKLY BULLISH
Full data via /api/advanced/JNJ
Valuation
| Metric | Value |
|---|---|
| Market Cap | 655.56B |
| P/E (TTM) | 41.32 |
| Forward P/E | N/A |
| P/B | 8.04 |
| EPS | 6.59 |
Financial Health
| Metric | Value |
|---|---|
| Revenue Growth | 5.9% |
| Profit Margin | 16.2% |
| ROE | 20.0% |
| Debt/Equity | 54.77 |
| Current Ratio | 1.02 |
| Dividend Yield | 2.0% |
| Payout Ratio | N/A |
| Beta | 0.20 |
Trading Data
272.32
Open
272.32
Day High
272.32
Day Low
9.65M
Volume (1.4x avg)
Price Chart (90 Days)
Candlesticks (green=up, red=down)
SMA 20
SMA 50
Bollinger Bands (upper/lower)
Volume (green=buying, red=selling)